Health Care & Life Sciences » Biotechnology | Atara Biotherapeutics Inc.

Atara Biotherapeutics Inc. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
51,615.00
104,116.00
320,676.00
255,876.00
166,290.00
309,825
Other Current Assets
193.00
1,910.00
3,921.00
4,677.00
5,900.00
11,664
Total Current Assets
51,808.00
106,026.00
324,597.00
260,553.00
172,190.00
321,489
Net Property, Plant & Equipment
8.00
48.00
270.00
3,259.00
44,129.00
68,576
Total Investments and Advances
-
-
-
-
1,200.00
1,200
Long-Term Note Receivable
335.00
-
-
-
-
-
Other Assets
12.00
48.00
108.00
102.00
260.00
574
Total Assets
52,163.00
106,122.00
324,975.00
263,914.00
217,779.00
391,839
ST Debt & Current Portion LT Debt
-
-
-
-
500.00
Income Tax Payable
155.00
1.00
-
-
-
Other Current Liabilities
1,369.00
2,723.00
9,709.00
9,675.00
27,146.00
Total Current Liabilities
1,524.00
2,724.00
9,709.00
9,675.00
27,646.00
Other Liabilities
230.00
216.00
166.00
503.00
12,269.00
Total Liabilities
1,754.00
2,940.00
9,875.00
10,178.00
39,915.00
Common Equity (Total)
10,682.00
103,182.00
315,100.00
253,736.00
177,864.00
Total Shareholders' Equity
50,409.00
103,182.00
315,100.00
253,736.00
177,864.00
Total Equity
50,409.00
103,182.00
315,100.00
253,736.00
177,864.00
Liabilities & Shareholders' Equity
52,163.00
106,122.00
324,975.00
263,914.00
217,779.00
Preferred Stock (Carrying Value)
61,091.00
-
-
-
-

About Atara Biotherapeutics

View Profile
Address
611 Gateway Boulevard
South San Francisco California 94080
United States
Employees -
Website http://www.atarabio.com
Updated 07/08/2019
Atara Biotherapeutics, Inc. operates as a clinical stage company which focuses on developing novel therapeutics for serious unmet medical needs, with an initial focus on muscle wasting conditions and oncology. Its product candidates are biologics targeting myostatin and activin, members of the transforming growth factor-beta, protein superfamily, which play roles in the growth and maintenance of muscle and many other body tissues. The company was founded by Isaac E.